Baszucki Group

What Baszucki Group does

Baszucki Group is a private social change venture, legally the Baszucki Family Foundation, founded in 2021 by David Baszucki (founder and CEO of Roblox, NYSE: RBLX) and Jan Ellison Baszucki, headquartered in San Mateo, California. The foundation directs philanthropic resources toward three pillars: metabolic and mental health (with a focus on metabolic psychiatry and ketogenic therapy as interventions for serious mental illness), regenerative agriculture, and electoral innovation. It serves four primary constituencies: academic researchers and clinical institutions conducting translational and clinical research in metabolic psychiatry (Universities of Edinburgh, McLean, Stanford, Oxford, Columbia, UC San Diego, Ohio State, and Toronto are listed grantees); early-stage companies at the intersection of metabolic health and mental health, accessed via an impact investing program deploying $100,000-$500,000 checks at pre-seed and seed; clinicians and healthcare providers seeking training in metabolic approaches to psychiatric care; and patients and families affected by serious mental illness who engage through the Metabolic Mind platform. The foundation operates without commercial revenue and does not sell products or services; it is funded by David Baszucki's personal resources from his Roblox CEO compensation.

The foundation's core "technology" is its metabolic psychiatry framework — a clinical thesis that brain energy metabolism dysfunction underlies many serious psychiatric conditions and can be addressed through ketogenic and metabolic interventions. Its "products" are programmatic: research grants to institutions (e.g., £1.17M to Oxford for a psychosis-risk RCT, $450K expanded to Cleveland Clinic Brain Study, $1.5M Baszucki Prize to Martin Picard at Columbia), prize and fellowship mechanisms (Metabolic Psychiatry Scholar Award at up to $150K per investigator across six recipients in 2025, Metabolic Psychiatry Fellowship, Fresh Start Awards of $10K to recovery advocates), impact investments in early-stage care-delivery companies, coalition advocacy (Coalition for Metabolic Health, Metabolic Collective, partnerships with NAMI, DBS Alliance, Charlie Foundation), and the Metabolic Mind nonprofit platform that provides education, community, and the Metabolic Mind podcast hosted by Dr. Bret Scher. Documented clinical outcomes from trials it funds include a 79% clinically meaningful psychiatric improvement rate at the Stanford pilot, 72% of anorexia nervosa completers no longer meeting diagnostic criteria after a 14-week ketogenic intervention at UC San Diego, and 75% of all Stanford participants in recovery at study conclusion.

The business and revenue model is philanthropic grantmaking combined with impact investing. Baszucki Group has no pricing model, no paying customers, and no disclosed revenue; it makes grants to researchers and institutions, equity investments in pre-seed/seed companies, and operates community/advocacy platforms. Distribution is direct partnerships with research institutions globally (USA, Canada, UK, Switzerland, Finland, Australia), with named advocacy partners serving as resellers for its metabolic psychiatry message, and with the Metabolic Mind platform as an owned public-facing storefront for education. The 20-30 person staff operates across programs, grants management, communications, finance, and operations, with leadership drawn from Stanford, Harvard, NIH, Google, Ford Foundation, Gates Capital, Earthjustice, Jazz Pharmaceuticals, and the Ontario Brain Institute.

Name

Baszucki Group

Legal name

Baszucki Family Foundation

Website

https://baszuckigroup.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Baszucki Group is a private family foundation, founded in 2021 by Roblox CEO David Baszucki and author Jan Ellison Baszucki, that funds metabolic psychiatry research, awards prizes and fellowships, makes impact investments in early-stage metabolic-health companies, and runs the Metabolic Mind nonprofit and Coalition for Metabolic Health to advance ketogenic and metabolic therapies for serious mental illness.

Ownership category

akta.pro rank

Product category

Philanthropy and Impact Investing

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

SIC

Services-Social Services (8300)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Behavioral Health & Substance Use Program Funding (Public Health) (HLAJALAI)

Keywords

• Philanthropic grantmaking
• Impact investing
• Metabolic psychiatry research
• Mental health advocacy
• Regenerative agriculture

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Philanthropic Grantmaking: Baszucki Group operates as a social change venture funded by David Baszucki's personal resources from Roblox. The organization makes grants to researchers, institutions, and organizations advancing metabolic health, mental health, and regenerative agriculture.
2. Impact Investing: The organization makes equity investments in early-stage companies at the nexus of metabolic health and mental health, typically investing $100,000 to $500,000 in pre-seed and seed-stage companies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Baszucki Group is a private social change venture that funds research, advocacy, and companies through philanthropic grantmaking and impact investing. Its core offerings include research grants to academic and clinical institutions studying ketogenic and metabolic therapies for mental illness, equity investments in early-stage companies in metabolic and mental health, the Metabolic Mind education and community platform, prize/award programs, and advocacy initiatives in metabolic health, regenerative agriculture, and electoral innovation. The organization does not sell commercial products or services; it operates as a foundation distributing capital and building community around metabolic psychiatry.

Product overview

Baszucki Group is a social change venture founded in 2021 by David Baszucki (Roblox CEO) and Jan Ellison Baszucki, operating as a philanthropy and impact investing organization rather than a traditional product company. Its core offerings include: (1) the Metabolic Mind sub-brand, encompassing educational resources, a podcast, and community platform for metabolic psychiatry; (2) research grantmaking programs funding metabolic therapies for mental illness; (3) impact investing in companies developing metabolic health solutions; (4) prize programs including the $1.5 million Baszucki Prize, Metabolic Psychiatry Scholar Awards, Fellowships, and Fresh Start Awards; (5) advocacy programs supporting mental health organizations; and (6) regenerative agriculture initiatives including documentary production. The organization does not develop or sell technology products but funds and partners with researchers, clinicians, and companies advancing metabolic health.

Differentiator

Problem solved

Functional benefit

Brands

• Baszucki Prize: A prize program recognizing individuals leveraging prior Baszucki Group funding to make exceptional contributions to science and medicine.
• Metabolic Mind Awards
• Baszucki Brain Research Fund
• Metabolic Psychiatry Scholar Award
• Fresh Start Awards
• Metabolic Mind

Products and services

• Research Grantmaking Program Philanthropic grants to academic researchers, universities, hospitals, and clinical institutions conducting translational and clinical research on metabolic therapies for mental illness, including support for clinical trials at Stanford, University of Oxford, McLean Hospital, UC San Diego, and other institutions.
• Impact Investing Program Equity investments in early-stage (pre-seed and seed) companies at the nexus of metabolic health and mental health, with typical investments of $100,000 to $500,000. Focus areas include metabolic psychiatry care delivery, mental health care delivery, food as medicine, and metabolic health measurement tools.
• Metabolic Mind Nonprofit initiative of Baszucki Group providing education, community, and resources on metabolic psychiatry for individuals, families, educators, and clinicians, including the Metabolic Mind Podcast hosted by Dr. Bret Scher.
• Metabolic Psychiatry Initiative Program area funding research on existing and emerging ketogenic and metabolic therapies for psychiatric disorders, with emphasis on quantitative approaches, mechanisms of action, predictive biomarkers, and clinical research investigating the link between metabolic function and psychiatric illness.
• Metabolic Neuroscience Initiative Initiative supporting high-impact research in metabolic neuroscience, facilitating the development and delivery of effective metabolic treatments for brain-based disorders through collaborations with pioneers in the field.
• Mental Health Advocacy Program Program investing in organizations that amplify voices of those with lived experience of mental illness to families, schools, providers, government agencies, and the general public, including partners like Bring Change to Mind, Metabolic Collective, and DBS Alliance.
• Regenerative Agriculture Initiative Initiative supporting regenerative farming and ranching through storytellers and advocates, including support for the documentary Common Ground and the 100 Million Acres campaign to advance regenerative agriculture practices.
• Bipolar Disorder Research Program (BD2) Program partnering with researchers to advance basic, translational, and clinical bipolar research, including the BD2 (Breakthrough Discoveries for thriving with Bipolar Disorder) global platform launched with the Milken Institute, Dauten and Brin families.
• Baszucki Prize in Science Prize program recognizing an individual or team leveraging prior Baszucki Group funding to make exceptional contributions to science and medicine, with the inaugural $1.5 million prize awarded to Martin Picard, PhD of Columbia University for work on brain energetics and mitochondria.
• Metabolic Psychiatry Scholar Award Funding initiative supporting and elevating outstanding early-career investigators bridging the fields of metabolism and mental health, with awardees receiving up to $150,000 over 18 months plus mentorship and professional development.
• Fresh Start Awards Award program by Metabolic Mind honoring individuals who have fought to recover their mental health through ketogenic therapy, with recipients receiving $10,000 each to support advocacy, education, and personal or professional development goals.
• Coalition for Metabolic Health Coalition led by Baszucki Group translating emerging metabolic science into policy opportunities and strategic initiatives to advance metabolic approaches in chronic disease, including serious mental illness, elevating metabolic health as a national priority.

Quantifiable outcome

• 72% of completers no longer met diagnostic criteria for anorexia nervosa after 14-week ketogenic intervention
• +5 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core.

• University of OxfordcoreStrategic or Co-development Partner · 22 May 2026£1.17 million grant to fund a randomized controlled trial evaluating whether a modified ketogenic diet can improve mental and physical health outcomes for patients at clinical high risk of psychosis. Trial enrolls 50 patients aged 14-35.
• Cleveland Clinic Neurological InstitutecoreStrategic or Co-development Partner · 10 December 2025Expanded commitment bringing total donation to $450,000 to include new biomarkers analysis in the landmark Cleveland Clinic Brain Study. The study aims to identify early markers of neurological diseases by tracking healthy individuals over 20 years.
• University of Maryland School of MedicinecoreStrategic or Co-development Partner · 4 December 2025Partnership to launch a training program on ketogenic metabolic therapy for mental health care. Initiative aims to educate healthcare professionals on implementing personalized ketogenic diets to treat mental illnesses.
• BD²: Breakthrough Discoveries for thriving with Bipolar DisordercoreStrategic or Co-development PartnerJoint initiative with Dauten and Brin families plus Milken Institute launched September 12, 2022 as a global platform coordinating science across disciplines and national borders to tackle bipolar disorder.
• Common Ground DocumentarycoreGTM or Marketing PartnerFeature-length documentary on regenerative agriculture with Jan Ellison Baszucki as Executive Producer. Premiered at 2023 Tribeca Film Festival and received Human/Nature Award.
• Coalition for Metabolic HealthcoreStrategic or Co-development PartnerCoalition translating emerging metabolic science into policy opportunities and strategic initiatives to advance metabolic approaches in chronic disease including serious mental illness.
• UC San Diego School of MedicinecoreStrategic or Co-development PartnerResearch partnership for pilot study on ketogenic therapy feasibility in anorexia nervosa. Guido Frank, MD led first-of-its-kind trial funded by Baszucki Group.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Schmidt Futures: Philanthropic venture of Eric and Wendy Schmidt funding 'science of science' and biomedical research, including early-career talent programs. Comparable in tech-billionate-driven, talent-and-prize-centric philanthropy model.
• Bill & Melinda Gates Foundation: The largest private philanthropic foundation globally, with major grantmaking programs in health research and global health delivery. Comparable in operating model (large-scale grantmaking plus advocacy) but materially larger and broader in mission.
• Wellcome Trust: One of the world's largest biomedical research charities, funding mental health, neuroscience, and metabolic research at scale. Comparable as a long-duration, science-led grantmaking foundation, though far larger and more diversified than Baszucki Group.
• Chan Zuckerberg Initiative: Philanthropic venture founded by a tech billionaire couple, funding biomedical research with both grantmaking and direct science operations (CZ Biohub). Comparable in founder-driven, venture-style philanthropy targeting ambitious science, though operating at much larger scale.

Emerging players

• Virta Health: A commercial healthcare company using ketogenic and low-carbohydrate interventions to reverse type 2 diabetes, with expanding interest in metabolic mental health. Representative of the type of early-stage company Baszucki Group's impact investing program targets, and a strategic comparator for translating metabolic therapies into mainstream care.

Direct peers

• Charlie Foundation: A nonprofit founded in 1994 to promote ketogenic dietary therapies, originally for pediatric epilepsy. Closely aligned with Baszucki Group's use of ketogenic interventions, and explicitly listed among Baszucki's mental health advocacy partners.
• Doris Duke Charitable Foundation: A family foundation funding medical research including mental health, with a portfolio approach that combines research grants, prize programs, and capacity-building — closely comparable to Baszucki Group's multi-vector model in mental health research.
• Brain & Behavior Research Foundation: The largest private funder of mental health research grants in the United States. Directly comparable to Baszucki Group's grantmaking model targeting serious mental illness, with a similar nonprofit research-funder structure.
• Milken Institute: Co-launched the BD2: Breakthrough Discoveries for thriving with Bipolar Disorder platform with Baszucki Group and other families, and runs research grant programs in metabolic and bipolar research — directly comparable as a partner and adjacent funder in the same therapeutic area.
• Stanley Medical Research Institute: Largest private funder of bipolar and schizophrenia research, funding translational and clinical studies worldwide. Closely comparable to Baszucki's metabolic psychiatry grantmaking focus on bipolar disorder and schizophrenia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCtZYo5tlvPznLFZARJg4v5Q
• LinkedInlinkedin.com/company/baszucki-group
• Instagraminstagram.com/metabolicmind

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Baszucki Group